Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,645 | 10 | 56.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,702 | 3 | 21.5% |
| Travel and Lodging | $7,791 | 27 | 12.3% |
| Food and Beverage | $3,434 | 56 | 5.4% |
| Honoraria | $3,000 | 1 | 4.7% |
| Education | $11.61 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | $19,323 | 46 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $14,549 | 11 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $10,664 | 13 | $0 (2024) |
| ALBIREO PHARMA, INC. | $6,135 | 3 | $0 (2023) |
| KADMON PHARMACEUTICALS LLC | $3,692 | 2 | $0 (2018) |
| Gilead Sciences, Inc. | $3,335 | 10 | $0 (2019) |
| ORPHALAN INC | $3,282 | 7 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $2,388 | 1 | $0 (2024) |
| Kadmon Corporation LLC | $183.33 | 3 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.13 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,482 | 41 | Ipsen Biopharmaceuticals, Inc ($10,597) |
| 2023 | $20,298 | 29 | Mirum Pharmaceuticals, Inc. ($9,897) |
| 2022 | $13,582 | 12 | Alexion Pharmaceuticals, Inc. ($13,544) |
| 2019 | $3,335 | 10 | Gilead Sciences, Inc. ($3,335) |
| 2018 | $3,703 | 3 | KADMON PHARMACEUTICALS LLC ($3,692) |
| 2017 | $183.33 | 3 | Kadmon Corporation LLC ($183.33) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Hepatology | ||||||
| 12/05/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Alagille syndrome | ||||||
| 12/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Alagille syndrome | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $2,388.00 | General |
| Category: CRITICAL CARE | ||||||
| 11/05/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Alagille syndrome | ||||||
| 10/29/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,046.00 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $145.13 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $57.63 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Hepatology | ||||||
| 09/23/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Hepatology | ||||||
| 09/10/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Alagille syndrome | ||||||
| 09/04/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Gastroenterology | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $250.72 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $149.85 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $116.46 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $99.24 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $69.64 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $33.62 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $143.48 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $118.66 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $28.26 | General |
| Category: Alagille syndrome | ||||||
| 07/16/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Hepatology | ||||||
| 07/11/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,046.00 | General |
| Category: Gastroenterology | ||||||
About Dr. Steven Lobritto, MD
Dr. Steven Lobritto, MD is a Pediatric Transplant Hepatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346229960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Lobritto, MD has received a total of $63,583 in payments from pharmaceutical and medical device companies, with $22,482 received in 2024. These payments were reported across 98 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($35,645).
Practice Information
- Specialty Pediatric Transplant Hepatology
- Location New York, NY
- Active Since 01/12/2006
- Last Updated 02/02/2026
- Taxonomy Code 2080T0004X
- Entity Type Individual
- NPI Number 1346229960
Products in Payments
- Livmarli (Drug) $19,323
- Bylvay (Drug) $16,800
- CUVRIOR (Drug) $3,282
- TERLIVAZ (Drug) $2,388
- GATTEX (Drug) $20.13
- (820) Cholbam (Drug) $11.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Transplant Hepatology Doctors in New York
Dr. Jennifer Vittorio, M.d, M.D
Pediatric Transplant Hepatology — Payments: $136,591
Dr. Mercedes Martinez, Md, MD
Pediatric Transplant Hepatology — Payments: $16,952
Pooja Reddy Spector, Md, Ms, MD, MS
Pediatric Transplant Hepatology — Payments: $584.27
Adriana Perez, M.d, M.D
Pediatric Transplant Hepatology — Payments: $113.56
Dr. Minoti Vather, Md, MD
Pediatric Transplant Hepatology